These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 17566465)
1. Vaccinating adolescents and young women against cancer of the cervix. Hilgers RD; Wyatt SW J Ky Med Assoc; 2007 May; 105(5):215-6. PubMed ID: 17566465 [No Abstract] [Full Text] [Related]
2. Papillomavirus vaccine types 16 and 18: new drug. Cervical cancer: just another vaccine. Prescrire Int; 2008 Jun; 17(95):103-4. PubMed ID: 18623911 [TBL] [Abstract][Full Text] [Related]
3. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health. Harper DM Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444 [TBL] [Abstract][Full Text] [Related]
4. [Cervical carcinoma and the vaccination experience with Cervarix]. Berberova M Akush Ginekol (Sofiia); 2012; 51 Suppl 1():4-5. PubMed ID: 23236670 [No Abstract] [Full Text] [Related]
5. Human papillomavirus genotype distributions inform screening and vaccination policy. Pinkowish MD CA Cancer J Clin; 2009; 59(5):280-1. PubMed ID: 19684300 [No Abstract] [Full Text] [Related]
6. [In defence of women against HPV-infection]. Blázovics A Orv Hetil; 2007 Apr; 148(17):813. PubMed ID: 17452313 [No Abstract] [Full Text] [Related]
7. Mathematical models of cervical cancer prevention in the Asia Pacific region. Goldie SJ; Diaz M; Kim SY; Levin CE; Van Minh H; Kim JJ Vaccine; 2008 Aug; 26 Suppl 12():M17-29. PubMed ID: 18945411 [TBL] [Abstract][Full Text] [Related]
8. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools]. Dillner J; Andrae B; Westermark B Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260 [No Abstract] [Full Text] [Related]
9. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention. Jenkins D Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221 [TBL] [Abstract][Full Text] [Related]
10. Cervarix--a second HPV vaccine. Med Lett Drugs Ther; 2010 May; 52(1338):37-8. PubMed ID: 20467355 [No Abstract] [Full Text] [Related]
11. Efficacy of HPV 16/18 vaccines on sexually active young women and the impact on organized cervical cancer screening. Giorgi Rossi P; Zorzi M Acta Obstet Gynecol Scand; 2010 Jun; 89(6):846-7; author reply 848. PubMed ID: 20504086 [No Abstract] [Full Text] [Related]
12. The quadrivalent human papillomavirus vaccine. Wheat A Med Health R I; 2008 Dec; 91(12):387-9. PubMed ID: 19170317 [No Abstract] [Full Text] [Related]
13. The economic impact of HPV vaccines: not just cervical cancer. Myers ER Am J Obstet Gynecol; 2008 May; 198(5):487-8. PubMed ID: 18455522 [No Abstract] [Full Text] [Related]
14. Human papillomavirus vaccine efficacy: aligning expectations with reality. Smith-McCune KK Gynecol Oncol; 2008 Oct; 111(1):1-2. PubMed ID: 18922296 [No Abstract] [Full Text] [Related]
15. Screening for cervical cancer: controversy and contention or thoughtful analysis. Frable WJ Cancer; 2007 Jun; 111(3):143-4. PubMed ID: 17487849 [No Abstract] [Full Text] [Related]
16. Adverse effects of papillomavirus vaccines: pharmacovigilance data in 2008. Prescrire Int; 2009 Aug; 18(102):163. PubMed ID: 19743577 [TBL] [Abstract][Full Text] [Related]
17. Who should get the HPV vaccine? Pichichero ME J Fam Pract; 2007 Mar; 56(3):197-202. PubMed ID: 17343808 [No Abstract] [Full Text] [Related]
18. Prevention of cervical cancer: where immunology meets diagnostics. Meijer CJ; Heideman DA; Berkhof H; Snijders PJ Immunol Lett; 2009 Feb; 122(2):126-7. PubMed ID: 19100775 [TBL] [Abstract][Full Text] [Related]
19. The new era of cervical cancer prevention: HPV vaccination. Monk BJ; Herzog TJ Gynecol Oncol; 2008 May; 109(2 Suppl):S1-3. PubMed ID: 18482553 [No Abstract] [Full Text] [Related]